Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about LEGN Recent news which mentions LEGN < Previous 1 2 3 4 Next > Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday Today 10:29 EDT Tickers BKU CHUY COMM CSIQ Tags MTLS big gainers LEGN From Benzinga The Latest Analyst Ratings For Legend Biotech July 15, 2024 Tickers LEGN Tags Analyst Ratings BZI/AAR Market News From Benzinga Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients July 02, 2024 Tickers JNJ LEGN NEWS Tags Briefs Benzinga Stories That Matter From Benzinga Assessing Legend Biotech: Insights From 15 Financial Analysts June 21, 2024 Tickers LEGN Tags Market News Benzinga LEGN From Benzinga Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst June 17, 2024 Tickers JNJ LEGN Tags Trading Ideas JNJ Health Care From Benzinga Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? June 09, 2024 Tickers ACLS AGIO HALO IRTC Tags TWST VRNT LEGN From Benzinga Unveiling 18 Analyst Insights On Legend Biotech June 04, 2024 Tickers LEGN Tags LEGN Benzinga Market News From Benzinga Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings) May 14, 2024 Tickers LEGN Tags Market News Benzinga LEGN From Benzinga LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024 May 13, 2024 Tickers LEGN Tags NASDAQ:LEGN LEGN Earnings Reports From InvestorPlace FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies April 19, 2024 Tickers BMY GILD JNJ LEGN Tags LEGN TSVT General From Benzinga Analyst Ratings For Legend Biotech April 17, 2024 Tickers LEGN Tags BZI/AAR Analyst Ratings LEGN From Benzinga Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population April 08, 2024 Tickers JNJ LEGN NEWS NVS Tags Equities News Large Cap From Benzinga Unveiling 9 Analyst Insights On Legend Biotech April 01, 2024 Tickers LEGN Tags Analyst Ratings BZI/AAR Benzinga From Benzinga GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy March 20, 2024 Tickers ASIA BMY JNJ LEGN Tags BMY Market News NVS From Benzinga FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer March 18, 2024 Tickers BMY JNJ LEGN NEWS Tags BMY why it's moving Market News From Benzinga FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers March 13, 2024 Tickers BMY JNJ LEGN NEWS Tags Large Cap News JNJ From Benzinga Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session March 13, 2024 Tickers BGNE CLOV HCM LEGN Tags CLOV BGNE Markets From Benzinga Earnings Scheduled For March 11, 2024 March 11, 2024 Tickers ALTO ASAN ASRT AVO Tags HSAI OSG GNE From Benzinga Earnings Preview: Legend Biotech March 08, 2024 Tickers LEGN Tags Benzinga Earnings LEGN From Benzinga Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley March 07, 2024 Tickers ACLX BMY GILD JNJ Tags ACLX Analyst Ratings Initiation From Benzinga What 4 Analyst Ratings Have To Say About Legend Biotech March 07, 2024 Tickers LEGN Tags Analyst Ratings BZI/AAR Benzinga From Benzinga Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment January 23, 2024 Tickers AZN BMY GILD GRCL Tags Market News NVS GILD From Benzinga As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks? January 10, 2024 Tickers ASIA BABA BGNE CHIR Tags BABA Markets BGNE From Benzinga Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024 January 04, 2024 Tickers ACLX JNJ LEGN NEWS Tags News Reiteration Trading Ideas From Benzinga Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback December 29, 2023 Tickers ALNY ARWR IBB LEGN Tags ARWR Analyst Color Market News From Benzinga Key Takeaways From Legend Biotech Analyst Ratings December 19, 2023 Tickers LEGN Tags Benzinga LEGN Market News From Benzinga Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say December 11, 2023 Tickers ACLX JNJ LEGN Tags General LEGN Briefs From Benzinga Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment November 20, 2023 Tickers BMY JNJ LEGN SPX Tags SPX TSVT JNJ From MarketWatch Earnings Scheduled For November 20, 2023 November 20, 2023 Tickers A BLRX BRBR CENT Tags XELB FANH YMM From Benzinga Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On November 16, 2023 Tickers CVRX JNJ LEGN NVS Tags JNJ Recent Press Releases CVRX From Motley Fool < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.